Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Fruquintinib Plus Checkpoint Inhibitor Combined or Sequential TAS-102 in Colorectal Cancer Patients Who Progressed on Second-line Standard Therapy: a Prospective, Multi-cohort, Single-centered, Phase Ib/II Study

Tianjin Medical University Cancer Institute and Hospital · 2023
ClinicalTrials.gov · Datasets · License: Public Domain · 2023
Open Source ↗
colorectal-cancer
colorectal cancer, fruquintinib, trifluridine/tipiracil, microsatellite stable, metastatic colorectal cancer, interventional, phase1, phase2
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 993962
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.